|
|
 |
PD 0325901 |
391210-10-9 |
|
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氫-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
|
PFI-4 抑制劑 |
900305-37-5 |
|
2-[[4-氨基-3-(3-羥基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基]甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 |
900185-02-6 |
|
N-[3-[(5-氯-1H-吡咯并[2,3-b]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
|
PP242 |
1092351-67-1 |
|
6-(2,4-二氟苯氧基)-8-甲基-2-[(四氫-2H-吡喃-4-基)氨基]-吡啶并[2,3-d]嘧啶-7(8h)-酮 |
449811-92-1 |
|
R-406 |
841290-80-0 |
|
FOSTAMATINIB 二鈉鹽 |
1025687-58-4 |
|
GSK-F1 |
1402345-92-9 |
|
2,4-Thiazolidinedione, 3-[[(3Z)-2,3-dihydro-3-[[4-(4-MorpholinylMethyl)-1H-pyrrol-2-yl]Methylene]-2-oxo-1H-indol-5-yl]Methyl]-, hydrochloride |
1265965-19-2 |
|
SAR-020106 |
1184843-57-9 |
|
SB-203580 |
152121-47-6 |
|
3-(2,4-二氯苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
280744-09-4 |
|
SB242235 |
193746-75-7 |
|
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 
